New Report Links Elmiron and Retinal Damage

In an article published in the Canadian Journal of Ophthalmology, researchers report a link between the interstitial cystitis medication Elmiron and retinal maculopathy in a group of patients studied at the University of California, Los Angeles. The researchers say that 20 percent of patients developed retinal damage from taking the drug, while the other percentage who didn’t took a lower dosage of Elmiron or for a shorter period, the New York Injury Law News reports.

Read more

The CAMG Legal Marketing Index®. Significantly increase your marketing success, on us.

CAMG’s Legal Marketing Index® offers unprecedented reporting and comprehensive analysis of real-time data. Because more intelligent marketing decisions mean a better ROI.

Scroll to Top